Owner YAMANOUCHI PHARMACEUTICAL CO., LTD.

Inventors YAHIRO, Kiyoshi; KOBAYASHI, Miki; TAKEUCHI, Makoto; IWATA, Masahiro; KAWANO, Noriyuki; KAIZAWA, Hiroyuki; TAKUWA, Tomofumi; TSUKAMOTO, Issei; SEO, Ryushi

Pub. Number AU-A-2002313223

PCT Number PCT/JP02/05926

PCT Pub. Number WO2002/102778

Priority 2001-182296 15.06.01 JP

Filing date 13 June 2002

Wipo publication date 2 January 2003

C07D 213/81 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/89 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 453/02 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 031/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 031/4418 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 031/4427 - containing further heterocyclic ring systems

A61K 031/443

A61K 031/4433

A61K 031/4436

A61K 031/4439

A61K 031/444

A61K 031/4545

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/4725

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 031/5355 - Non-condensed oxazines containing further heterocyclic rings

A61K 031/5377

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/04 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 009/04 Drugs for disorders of the cardiovascular system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 011/00 Drugs for disorders of the respiratory system

A61P 011/04 Drugs for disorders of the respiratory system

A61P 011/06 Drugs for disorders of the respiratory system

A61P 013/12 Drugs for disorders of the urinary system

A61P 019/02 Drugs for skeletal disorders

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 031/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics